Skip to main content
. 2018 Feb 20;118(6):763–769. doi: 10.1038/bjc.2017.480

Figure 2.

Figure 2

Overall survival by RMH and MDACC Score Kaplan–Meier survival analysis and Cox proportional hazard regression analysis for overall survival in patients treated on ICI phase 1 trials, by: (A) RMH risk score. The cohort is divided into three risk groups based on the number of factors present: 0 (n=80, blue), 1 (n=60, purple), 2–3 (n=30, green). (B) MDACC risk score. The cohort is divided into three risk groups based on the number of factors present: 0–1 (n=76, blue), 2 (n=59, purple), 3–5 (n=35, green). ICI=immune checkpoint inhibitor therapy; MDACC=MD Anderson Cancer Center; RMH=Royal Marsden Hospital.